European Pharmaceutical Review

DECEMBER 14, 2023

Our research showed that in Europe between 1999 and 2016, 35 products were withdrawn. 1,2 This signals a promising trend towards a more comprehensive and diversified approach in regulatory decision-making. Meta-analyses contributed least frequently (31.4

Safety 113

Safety Medicine Competition Networking 113

PM360

APRIL 25, 2023

Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. since the first biosimilar launched in 2016, with more than a dozen branded drugs now with biosimilar competitors. pharmaceutical industry.

Marketing 97

Marketing Competition Government Manufacturing 97

World of DTC Marketing

JUNE 1, 2021

Since that time, Biogen’s MS drugs have faced intense competition as MS patients continue to vent on social media that the Biogen drug has nasty side effects. After the CEO departed the sinking ship, new management pinned all their hopes on the Biogen drug for Alzheimer’s.

Side effects 187

Side effects FDA Patients Doctors 187

PM360

OCTOBER 25, 2023

If the requirement that everything sold in-state must be grown in-state is eliminated, high cost, primarily indoor cultivation states in the Midwest and Northeast could see their entire grow industry put at an insurmountable competitive disadvantage. If rescheduling survives all these hurdles, there are still some major unknowns.

Food and Drug Administration 119

Food and Drug Administration FDA Insurance Medical 119

European Pharmaceutical Review

OCTOBER 27, 2023

If achieved, this would boost the UK’s competitiveness as a leading international site for trials. This is according to a 2016 paper published in Clinical and Translational Oncology. Timeframes to set up trials were reduced (on average) by 15 percent within a year of the legislation coming into force.”

Ethics 88

Ethics Medicine Education Competition 88

pharmaphorum

DECEMBER 2, 2022

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and precision medicine targeting more niche patient populations. 2016; 50(4):436-441; Tufts CSDD Impact Report. This emphasises sponsors’ need for enrolment predictability. Getz, Kenneth. March 2022.

Competition 93

Competition Leads Patients Electronics 93

pharmaphorum

JULY 15, 2022

At the time, she said, “companies have to respect our competition rules and procedures. An investigation into the cash-and-stock acquisition was opened by the Commission last year, but Illumina opted to go ahead and complete the merger while the outcome was still pending, inciting the ire of EU antitrust chief Margrethe Vestager.

Competition 52

Competition Medicine Marketing Sales 52

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 87

Government Recruitment Medicine Competition 87

PM360

JUNE 26, 2023

This can be especially important in the current global economic climate, where competition for market share is fierce, and access to new customers is critical for growth. Firstly, entering new markets and increasing sales should boost revenue. In a shareholder meeting, Merck & Co.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

Clarivate

JANUARY 30, 2023

As we note in our white paper, a 2016 European Commission report suggested that only between 10 to 50% of patents declared to be essential in the ETSI actually are. Although the change in policy was presented by the agencies as promoting innovation and competition, it may lead to increased uncertainty and litigation around SEPs.

Marketing 52

Marketing Management Education Competition 52

Clarivate

MAY 31, 2023

biotech Cambridge Antibody SKYRIZI® (risankizumab) was part of a 2016 deal with Boehringer Ingelheim IMBRUVICA® (ibrutinib) was originally invented by Celera Genomics. AbbVie’s biggest selling drugs all came to the company through in-licensing or acquisitions: HUMIRA® (adalimumab) was developed by U.K.

Pharma 52

Pharma Biopharma Medicine Competition 52

PM360

MARCH 24, 2023

Starting with Vermont in 2016, more than half of the U.S. When the states realize that price discovery and competition already exist and that the real mark-ups take place at the pharmacy benefit manager (PBM) and retail pharmacy levels, manufacturers will have to comply and report.

Manufacturing 96

Manufacturing Retail Management Distribution 96

Pharmaceutical Technology

AUGUST 31, 2022

This forward-looking approach ranks Costa Rica as the top Latin American country in human capital, workforce skills and quality education, according to the WEF’s 2019 Global Competitiveness Report, and today its plethora of human talent is one of its key competitive differentiators for attracting foreign investors.

Education 52

Education Training Competition Manufacturing 52

Clarify Health

MARCH 1, 2023

This delicate balance taps into physician’s natural competitive tendencies, but bounds these tendencies in shared goals and joint commitment. Healthcare (2016), [link] [2] Parikh, R. Annals of Internal Medicine: Medicine and Public Issues (2016), [link] [4] Navathe, A. Manuscript in Preparation]. [3]

Physicians 52

Physicians Prescription Medicine Healthcare 52

Contrarian Sales Techniques

DECEMBER 22, 2020

The lead includes more than 1,000 biotech start-ups created between 2012 and 2016, with a further 500 founded in 2017. According to the World Economic Forum's 2017 Global Competitiveness Report, the Association of Southeast Asian Nations (ASEAN) is on track to become Asia's next economic powerhouse.

Government 52

Government Competition Pharmaceutical Management 52

European Pharmaceutical Review

JUNE 24, 2022

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. Maarten has significant competition law experience in a variety of sectors. References.

Pharmaceutical 100

Pharmaceutical Medicine Marketing Competition 100

European Pharmaceutical Review

OCTOBER 19, 2022

2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” 26 April, 2016. References. Why Patents Are the Lifeblood Of Biotech Companies.

Food and Drug Administration 76

Food and Drug Administration Pharmaceutical products Pharmacology FDA 76

PharmaKinnex

AUGUST 23, 2022

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. Let’s dive into the current state of the pharma industry and learn more about what your team can do to stay ahead of the curve and the competition. The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

Pharma 52

Pharma Sales Sales Strategy Marketing 52

Clarivate

OCTOBER 26, 2021

Despite the turbulent economic landscape, the number of patents in force grew to over 15m worldwide in 2020, with an average 7% annual growth 2016-2019. When rights are lost, the rest of the market can capitalize, stripping away years of innovation and competitive advantage – alongside the revenue associated to those rights.

Networking 52

Networking Management Leads Insurance 52

The Brooks Group

NOVEMBER 9, 2015

Think “Outselling Lower Priced Competition” or “Strategic Account Management,” for example. Keep this list of “don’ts” in mind when you’re planning your 2016 sales kickoff meeting. Your reps will come away from the 1-day program with solid, actionable prospecting checklists and a concrete plan for hitting their numbers in 2016.

Sales 53

Sales Sales Management Sales territory Networking 53

Pharma Marketing Network

DECEMBER 17, 2021

Johnson & Johnson was one of the first major companies to make a public commitment to the SDGs in 2016. Increasing competition for talent, as well as the uncertainty of remote versus in-person workspaces, impacts new hire engagement.

Pharma 103

Pharma Ethics Recruitment Government 103

MedTechVets

JANUARY 7, 2021

In 2016, A center For a New American Security released a study that said 60% of veterans felt that their skills and experiences were more advanced than the requirements of their job. This gives a company competitive advantage, especially in a global market. That same study stated that 18.7%

Training 52

Training Management Networking Medical 52

Sales Talent

FEBRUARY 7, 2020

Linkedin’s 7 Predictions on How Recruiting Will Be Different in 2025 shows that “the demand for recruiting professionals has jumped by 63% since 2016, and we expect that trend to continue.”. It also means that employers face the most competitive, candidate-driven employment market in history.

Sales 52

Sales B2B Sales Recruitment Marketing 52

CloserIQ

OCTOBER 10, 2018

Founded 2016. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Salsify offers competitive benefits and a flexible vacation plan. Revulytics is growing quickly, having acquired Trackerbird Software Analytics in 2016. 11-50 employees. $12 See open roles.

Sales 76

Sales Management Education Marketing 76

Evolve Your Success

MAY 23, 2023

With VR simulations, sales reps can now hone their skills in lifelike scenarios, giving them a competitive edge in the field. Osso was founded in 2016. I landed this competitive scholarship at the National Cancer Institute at school. There’s a little bit of a competitive streak in me and a lot of us in sales.

Training 52

Training Medical Sales Medical sales 52

World of DTC Marketing

JANUARY 31, 2021

2wo: The number of mergers and acquisitions(M&A) involving one of the top 25 firms in the pharmaceutical industry more than doubled from 2006 to 2016, and the practice doesn’t seem to be abating. So where to start… Congresswoman Porter may want to look at the percentage of generic drugs available virus branded (89%).

Pharma 187

Pharma Insurance Healthcare Healthcare 187

Spotio

OCTOBER 26, 2023

stars / 464 reviews Wingman was founded in 2016, purchased by Clari in 2022, and quickly renamed Clari Copilot. We started seeing results in less than a week and our sales numbers are growing.” ” – Atharva V. Verified G2 Reviewer Clari Copilot (Formerly Wingman) G2 rating : 4.5

Sales Management 52

Sales Management Sales Management Training 52

pharmaphorum

JANUARY 9, 2023

Compared to major primary care markets of the late 1990s/early 2000s, specialty care markets see more and earlier competitive launches, and the market share achieved by each launch after is progressively reduced. Research and development spend by major companies has increased 44% since 2016.

Medicine 80

Medicine Healthcare Healthcare Pharma 80

World of DTC Marketing

JUNE 22, 2021

SKIMMERS SUMMARY: There is one and only one social responsibility of business–to use its resources and engage in activities designed to increase its profits so long as it stays within the rules of the game, which is to say, engages in open and free competition without deception or fraud. Milton Friedman.

Patients 156

Patients Food and Drug Administration Pharma Government 156

pharmaphorum

JANUARY 4, 2023

It has been proposed that the amount of these fees charged by the data holder must be transparent, proportionate, and “must not restrict competition” 10. General Data Protection Regulation 2016/679. References. European Health Data Space: Regulation 2022/0140. Explanatory Memorandum, Section 2 of the Proposal.

Pharmaceutical 83

Pharmaceutical Electronics Healthcare Healthcare 83

Clarivate

MAY 24, 2023

An earlier Sarepta DMD drug, the antisense oligonucleotide (ASO) treatment EXONDYS 51, was priced at $300,000 a year for the average patient when it won FDA approval in 2016. With 11 gene therapies already approved payers are bracing for impact as Cortellis Competitive Intelligence data identifies another 30 in late-stage pipelines.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

Evolve Your Success

DECEMBER 20, 2022

They are going to start seeing all this competition from all these smaller brands that do social better. To tie this together, in the next 5 to 10 years, I see that influencer model continuing to grow at the individual level. I see these brands, especially the big boys starting to wake up, not because they see the light.

Medical sales 52

Medical sales Media Sales Medical sales reps 52

pharmaphorum

JUNE 29, 2022

Kirstie has over 5 years’ experience in healthcare and life sciences, previously working to provide industry expertise and analytics which support industry associations to influence health policy, and providing clinical and commercial competitive insights for pharmaceutical companies. Launches, therefore, were happening.

Doctors 57

Doctors Medicine Marketing Prescription 57

Pharmaceutical Technology

MAY 22, 2023

In an August 2022 statement , Moderna stated its technology contained within patents filed between 2010 and 2016 was copied without permission. CureVac’s lawsuits add to a complex legal landscape for Pfizer/BioNTech that already includes ones from Moderna. Pfizer/BioNTech then countersued in December 2022.

Biopharma 116

Biopharma Prospecting Competition Pharmaceutical 116

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Indeed, Amgen’s biosimilar was approved in September 2016, but the company was not able to launch it until January 2023 in the US. Biosimilar uptake could be more gradual.

Marketing 104

Marketing Physicians Competition Patients 104

Pharmaceutical Technology

JUNE 21, 2023

More recently, the regulatory agency also approved the therapy to reduce the risk of cardiovascular death in adults in 2016 , and to treat chronic heart failure in 2022. The FDA first approved Jardiance to help control blood sugar in adults with T2D in 2014. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Medicine 59

Medicine FDA Food and Drug Administration Sales 59

Pharmaceutical Technology

MAY 17, 2023

Obeticholic acid or OCA is a farnesoid X receptor agonist and is marketed by Intercept under the name Ocaliva for use against primary biliary cholangitis, following an approval in May 2016. Bezafibrate is a peroxisome proliferator-activated receptor agonist. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Food and Drug Administration 52

Food and Drug Administration FDA Pharmaceutical Prospecting 52